Sectors

GRI
GRI Bio, Inc.
1.77
2 x 1.71
1 x 1.85
bid
ask
-
0.18
9.23%
1 @ 04:00 PM
1.85 +0.08 (4.50%)
Ytd-74.42%
1y-95.14%
1.71
day range
1.90
1.36
52 week range
80.36
Open1.90Prev Close1.95Low1.71High1.90Mkt Cap159.00K
Vol182.35KAvg Vol177.37KEPS-52.02P/E-0.03Forward P/E-0.29
Beta-1.21Short Ratio0.10Inst. Own4.71%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.79200-d Avg11.141yr Est11.50
Income Statement
Operating Expenses2.00M
Research and Development Expense361.00K
Selling, General and Administrative Expense1.64M
Operating Income-2.00M
Net Income-2.00M
Net Income Common Stock-2.00M
Net Income Common Stock (USD)-2.00M
Consolidated Income-2.00M
Earnings per Basic Share-1.61
Earnings per Basic Share (USD)-1.61
Earnings per Diluted Share-1.61
Earning Before Interest & Taxes (EBIT)-2.00M
Earning Before Interest & Taxes (USD)-2.00M
Weighted Average Shares1.24M
Weighted Average Shares Diluted1.24M
Balance Sheet
Cash and Equivalents11.05M
Cash and Equivalents (USD)11.05M
Current Assets11.28M
Property, Plant & Equipment Net60.00K
Total Assets11.34M
Debt Current58.00K
Total Debt58.00K
Current Liabilities794.00K
Total Liabilities794.00K
Accumulated Retained Earnings (Deficit)-53.69M
Shareholders Equity10.55M
Shareholders Equity (USD)10.55M
Assets Non-Current60.00K
Total Debt (USD)58.00K
Trade and Non-Trade Payables303.00K
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow from Financing6.50M
Net Cash Flow / Change in Cash & Cash Equivalents2.82M
Issuance (Purchase) of Equity Shares6.50M
Net Cash Flow from Operations-3.68M
Share Based Compensation31.00K